Development of Cell & Gene Therapy

At 3D-PharmXchange, we have an all-encompassing experience advancing the development of cell and gene therapies (CGT), through a comprehensive approach that spans all four critical disciplines of drug development: CMC, non-clinical development, clinical development, and regulatory affairs.

Our expert team offers tailored support at each stage of the process, with CMC experts that can support in development of manufacturing processes to ensure the robustness of the process and the quality of CGT products. In non-clinical development, we provide strategic insights into preclinical models that effectively demonstrate therapeutic efficacy and safety. Our clinical development services focus on designing robust trials that meet the unique challenges posed by CGT, ensuring effective patient recruitment.

Navigating the complex regulatory landscape is crucial for the success of CGT. Our regulatory affairs specialists guide clients through the intricacies of CGT specific guidance, facilitating communication with health authorities to streamline the approval process.

Whether you are a start-up, SME, or an established pharmaceutical company, 3D-PharmXchange is your strategic partner in accelerating the journey from innovation to patient delivery, ensuring that groundbreaking therapies reach those in need as efficiently as possible.